314 related articles for article (PubMed ID: 6133664)
1. Clinical pharmacokinetics of the newer benzodiazepines.
Greenblatt DJ; Divoll M; Abernethy DR; Ochs HR; Shader RI
Clin Pharmacokinet; 1983; 8(3):233-52. PubMed ID: 6133664
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB
Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030
[TBL] [Abstract][Full Text] [Related]
3. Benzodiazepine metabolism: an analytical perspective.
Mandrioli R; Mercolini L; Raggi MA
Curr Drug Metab; 2008 Oct; 9(8):827-44. PubMed ID: 18855614
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of benzodiazepines: metabolic pathways and plasma level profiles.
Jochemsen R; Breimer DD
Curr Med Res Opin; 1984; 8 Suppl 4():60-79. PubMed ID: 6144464
[TBL] [Abstract][Full Text] [Related]
5. Short half-life benzodiazepines.
Greenblatt DJ; Shader RI
Ration Drug Ther; 1984 Apr; 18(4):1-5. PubMed ID: 6150514
[No Abstract] [Full Text] [Related]
6. Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.
Pourbaix S; Desager JP; Hulhoven R; Smith RB; Harvengt C
Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):447-51. PubMed ID: 2864320
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of benzodiazepine hypnotics.
Greenblatt DJ; Divoll M; Abernethy DR; Locniskar A; Shader RI
Int Pharmacopsychiatry; 1982; 17 Suppl 2():70-5. PubMed ID: 6145683
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of benzodiazepine hypnotics.
Greenblatt DJ; Divoll M; Abernethy DR; Locniskar A; Shader RI
Pharmacology; 1983; 27 Suppl 2():70-5. PubMed ID: 6142469
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the newer benzodiazepines.
Garzone PD; Kroboth PD
Clin Pharmacokinet; 1989 Jun; 16(6):337-64. PubMed ID: 2567646
[TBL] [Abstract][Full Text] [Related]
10. Triazolam, an anomalous benzodiazepine receptor ligand: in vitro characterization of alprazolam and triazolam binding.
Clow A; Glover V; Sandler M
J Neurochem; 1985 Aug; 45(2):621-5. PubMed ID: 2861251
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects.
Jochemsen R; Wesselman JG; van Boxtel CJ; Hermans J; Breimer DD
Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):291S-297S. PubMed ID: 6140948
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic properties of benzodiazepine hypnotics.
Greenblatt DJ; Abernethy DR; Divoll M; Harmatz JS; Shader RI
J Clin Psychopharmacol; 1983 Apr; 3(2):129-32. PubMed ID: 6132931
[TBL] [Abstract][Full Text] [Related]
13. The influence of obesity on the pharmacokinetics of oral alprazolam and triazolam.
Abernethy DR; Greenblatt DJ; Divoll M; Smith RB; Shader RI
Clin Pharmacokinet; 1984; 9(2):177-83. PubMed ID: 6143633
[TBL] [Abstract][Full Text] [Related]
14. Interaction of propoxyphene with diazepam, alprazolam and lorazepam.
Abernethy DR; Greenblatt DJ; Morse DS; Shader RI
Br J Clin Pharmacol; 1985 Jan; 19(1):51-7. PubMed ID: 2858217
[TBL] [Abstract][Full Text] [Related]
15. Rebound insomnia and elimination half-life: assessment of individual subject response.
Bixler EO; Kales JD; Kales A; Jacoby JA; Soldatos CR
J Clin Pharmacol; 1985 Mar; 25(2):115-24. PubMed ID: 2859304
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of benzodiazepines. Short-acting versus long-acting.
Breimer DD; Jochemsen R; von Albert HH
Arzneimittelforschung; 1980; 30(5a):875-81. PubMed ID: 6106488
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I).
Greenblatt DJ; Harmatz JS; Shader RI
Clin Pharmacokinet; 1991 Sep; 21(3):165-77. PubMed ID: 1684924
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics and biotransformation of the new benzodiazepine lormetazepam in humans. I. Absorption, distribution, elimination and metabolism of lormetazepam-5-14C.
Hümpel M; Illi V; Milius W; Wendt H; Kurowski M
Eur J Drug Metab Pharmacokinet; 1979; 4(4):237-43. PubMed ID: 43806
[TBL] [Abstract][Full Text] [Related]
19. Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788.
Klotz U; Duka T; Dorow R; Doenicke A
Br J Clin Pharmacol; 1985 Jan; 19(1):95-8. PubMed ID: 3919752
[TBL] [Abstract][Full Text] [Related]
20. Determination of biological activity of alprazolam, triazolam and their metabolites.
Sethy VH; Harris DW
J Pharm Pharmacol; 1982 Feb; 34(2):115-6. PubMed ID: 6121870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
